Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Prothya Biosolutions logo — Prothya Biosolutions aims to be a center of excellence in pr...

Prothya Biosolutions

Prothya Biosolutions aims to be a center of excellence in protein therapies for leading pharmaceutical companies.

Founded 2021 Belgium Belgium 712 employees Private Equity Biopharma, Biotechnology +2

General Information

Company Name Prothya Biosolutions
Founded Year 2021
Location Belgium Belgium
Founders / Decision Makers
Team member
Employees 712
Industries Biopharma, Biotechnology, Life Sciences +1
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with Prothya Biosolutions. To contact Prothya Biosolutions, visit prothya.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Prothya Biosolutions compare?

A PDF of Prothya Biosolutions and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Prothya Biosolutions soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Prothya Biosolutions

Prothya Biosolutions is a burgeoning startup in Belgium, specializing in protein therapies for major pharmaceutical companies. Established in 2021, it is the result of the integration of Plasma Industries Belgium (PIBe) and Sanquin Plasma Products (SPP), which brings together over 60 years of experience in blood plasma collection and the production of plasma-derived medicinal products. The company's expertise, inherited from its predecessors, encompasses the development of stable plasma derivatives like clotting factors, immunoglobulins, and albumin solutions. Prothya Biosolutions' commitment to leveraging the human plasma proteome's potential for revolutionizing disease diagnosis and therapeutic treatment showcases its innovative approach. The company processes approximately 3 million liters of plasma annually for various international partners, underscoring its significant production capacity. In line with its transformation into a results-oriented global organization, Prothya Biosolutions advocates for the intrinsic value of plasma-derived medicinal products for individuals and society. This approach reflects the company's revamped corporate culture epitomized by the DRIVE vision, constituting its foundational principles. Emphasizing collaboration, innovation, and the delivery of science-based solutions, Prothya Biosolutions invites individuals and potential partners to contribute to improving the health of millions of patients and participate in the forefront of Protein Therapy Development, Processing, and Manufacturing.

Business keywords: Protein Therapies, Pharmaceutical Industry, Plasma-derived Medicinal Products, Blood Plasma Collection, Protein Therapy Development, Global Organization, Corporate Culture, Healthcare Innovation, Medical Research, Biopharmaceuticals, Disease Diagnosis, Therapeutic Treatment, Healthcare Partnerships, Medical Manufacturing, Healthcare Solutions

No funding data available for Prothya Biosolutions yet.

Prothya Biosolutions Alternatives & Competitors

View All Alternatives
Prothya Biosolutions vs
Taibang Biological Group
Taibang Biological Group

Offering comprehensive development, manufacture, and sale of plasma-derived and biopharmaceutical pr...

Private Equity
Biopharma, Biotechnology
Compare Prothya Biosolutions vs Taibang Biological Group
Prothya Biosolutions vs
Aro Biotherapeutics
Aro Biotherapeutics United States

Series B
51 employees
Biotechnology, Health Care
Compare Prothya Biosolutions vs Aro Biotherapeutics
Prothya Biosolutions vs
Octapharma Plasma, Inc.
Octapharma Plasma, Inc. United States

Turn plasma into hope.

2933 employees
Biotechnology, Health Care
Compare Prothya Biosolutions vs Octapharma Plasma, Inc.
View all alternatives

FAQ About Prothya Biosolutions

Prothya Biosolutions aims to be a center of excellence in protein therapies for leading pharmaceutical companies.
Prothya Biosolutions was founded in 2021.
Prothya Biosolutions is headquartered in Belgium.
Prothya Biosolutions operates in Biopharma, Biotechnology, Life Sciences and Pharmaceutical. Its work centres on Protein Therapies, Pharmaceutical Industry, Plasma-derived Medicinal Products and Blood Plasma Collection.
Prothya Biosolutions has approximately 712 employees.
Top alternatives and competitors to Prothya Biosolutions include Taibang Biological Group, Aro Biotherapeutics, Octapharma Plasma, Inc., KAMADA, Gan & Lee Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Prothya Biosolutions and Taibang Biological Group are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Prothya Biosolutions, https://bouncewatch.com/company/prothya-biosolutions, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout